2 protocol(s) meet the specified criteria
PI: Moschos, Stergios
Protocol No.TitleStatus
LCCC1620Phase 2 Study of Denosumab in Combination with a PD-1 Inhibitor in Patients with Unresectable Stage III/IV Cutaneous MelanomaOpen
SNDX-275-0601A Phase 1b/2, Open-label, Dose Escalation Study of Entinostat in Combination with Pembrolizumab in Patients with Non-small Cell Lung Cancer, with Expansion Cohorts in Patients with Non-small cell Lung Cancer, Melanoma, and Mismatch Repair-Proficient Colorectal CancerOpen